Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bidlack

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
NIDA Research Monograph|January 1, 1986
Binding to mu and delta opioid sites but not kappa sites is inhibited by Fab fragments from a monoclonal antibody directed against the opioid receptorJ M Bidlack
Clinical and Diagnostic Laboratory Immunology|September 6, 2000
Detection and function of opioid receptors on cells from the immune systemJ M Bidlack
Annals of the New York Academy of Sciences|July 27, 2000
Pharmacological profiles of kappa opioids. Correlation between [35S]GTP gamma S binding and cyclic AMP productionJ M Bidlack, I Jadrovski
Molecular Pharmacology|October 1, 1992
Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cellsS Gucker, J M Bidlack
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1992
Effects of beta-endorphin on mu and delta opioid receptor-coupled G-protein activity: low-Km GTPase studiesD E Selley, J M Bidlack
Progress in Clinical and Biological Research|January 1, 1990
Morphine enhancement of mitogen-induced T-cell proliferationJ M Bidlack, L M Hemmick
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Differential kappa-opioid receptor expression on mouse lymphocytes at varying stages of maturation and on mouse macrophages after selective elicitationT A Ignatowski, J M Bidlack
The Journal of Biological Chemistry|December 15, 1985
A monoclonal antibody capable of modulating opioid binding to rat neural membranesJ M Bidlack, R R Denton
International Immunopharmacology|May 23, 2001
Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activityI Martin-Kleiner, J M Bidlack
Journal of Neuroimmunology|June 1, 1989
Beta-endorphin suppresses rat plaque-forming cell response by a non-opioid mechanismL M Hemmick, J M Bidlack
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
NIDA Research Monograph|January 1, 1986
Binding to mu and delta opioid sites but not kappa sites is inhibited by Fab fragments from a monoclonal antibody directed against the opioid receptorJ M Bidlack
Clinical and Diagnostic Laboratory Immunology|September 6, 2000
Detection and function of opioid receptors on cells from the immune systemJ M Bidlack
Annals of the New York Academy of Sciences|July 27, 2000
Pharmacological profiles of kappa opioids. Correlation between [35S]GTP gamma S binding and cyclic AMP productionJ M Bidlack, I Jadrovski
Molecular Pharmacology|October 1, 1992
Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cellsS Gucker, J M Bidlack
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1992
Effects of beta-endorphin on mu and delta opioid receptor-coupled G-protein activity: low-Km GTPase studiesD E Selley, J M Bidlack
Progress in Clinical and Biological Research|January 1, 1990
Morphine enhancement of mitogen-induced T-cell proliferationJ M Bidlack, L M Hemmick
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Differential kappa-opioid receptor expression on mouse lymphocytes at varying stages of maturation and on mouse macrophages after selective elicitationT A Ignatowski, J M Bidlack
The Journal of Biological Chemistry|December 15, 1985
A monoclonal antibody capable of modulating opioid binding to rat neural membranesJ M Bidlack, R R Denton
International Immunopharmacology|May 23, 2001
Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activityI Martin-Kleiner, J M Bidlack
Journal of Neuroimmunology|June 1, 1989
Beta-endorphin suppresses rat plaque-forming cell response by a non-opioid mechanismL M Hemmick, J M Bidlack
Pageof 10